Cell & Gene Therapy Manufacturing & Commercialization

FUJIFILM Diosynth Biotechnologies is delighted to be sponsoring Cell & Gene Therapy Manufacturing & Commercialization, December 5-8, 2022 in Amsterdam. Schedule a meeting via connectme app or stop by booth #20 to meet our team to learn more about FUJIFILM Diosynth Biotechnologies’ capabilities and how we can help you advance and deliver tomorrow’s medicines.

Join our Presentation December 6th @ 15:00
Michael Baker, Senior Director Viral Gene Therapy, FUJIFILM Diosynth Biotechnologies’, UK is presenting on Integrated Solutions for Global Viral Vector Manufacture 

• As the curative potential of gene therapies are unlocked, the need for globally integrated development and manufacturing solutions for the production of viral vectors becomes critical to meet patient needs.  FUJIFILM Diosynth Biotechnologies’ (FDB) globally integrated AAV development and manufacturing solutions coupled with harmonised facility design expedites the advancement through clinical phases in a geographically unconstrained manner.  Here we describe how FBD’s AAV manufacturing solutions, capability and capacity supports our clients from pre-clinical to commercial and beyond, ensuring the delivery of life saving therapeutics in the right place at the right time.

Click here for the complete agenda and registration